Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huayi Pharmaceutical is a prominent Chinese Contract Development and Manufacturing Organization (CDMO) that specializes in the development and commercial production of oral solid dosage forms. Established in 2006 and based in Hefei, China, the company was one of the first in the region to achieve EU GMP certification, enabling it to supply finished pharmaceutical products directly to the European market. Huayi provides a full suite of services including formulation development, analytical method validation, clinical trial material manufacturing, and large-scale commercial production. The company serves as a strategic bridge for international pharmaceutical firms looking to manufacture in China for global distribution, as well as for Chinese companies seeking to enter Western markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huayi Pharmaceutical.